Glipizide
Product Images NDC 66336-269

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 66336-269). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 66336-0269-xx (Ndc 66336 0269 Xx Patheon)

This is a medication with the active component Glipizide ER 10 mg. The product comes in a white, coated, round tablet with WPI 845 printed in black, packed in a light-resistant container. The medication should be taken orally once a day with breakfast, swallowed whole, and not chewed, crushed, or divided. The medication may cause drowsiness or dizziness, and alcohol should be avoided. Each tablet is extended-release, and the medication should be kept in a controlled temperature environment between 68-77°F. The medication should be kept away from children. The manufacturer is Patheon Pharmaceuticals INC. located in Cincinnati, OH 45237.*

FDA Label Image

Structural Formula For Glipizide (Glipizide Extended Release Tablet 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.